PJVN

PJVN

USD/ZAR RSI close to around January and July levels. Could test short-term support @ R13.80 should the ZAR strengthen further. 200-DMA at R14.57. R14.00 key psychological level.

PJVN

Astral Foods building some momentum post the annual results. A test of the intra-day high of R205.35 made on the 5th of September could be on the cards. The share is now trading above its 200-day MA.

PJVN

Currently, trading @ R165.49 – The 50-day moving average @ R163.56 could provide some support. A push higher and a test of the 200-day MA @ R177.68 is possible. Horizontal support around R143. Horizontal resistance around R195.

PJVN

Super Group could find some support at R27. The share is trading in a range of between R27 and R30.19. The 50-day MA could @ R28.88 could act as an initial resistance point.

PJVN

250-day moving average @ R29.50 could provide support. RSI now at oversold levels. Afrimat should report its interim results in October/November.

PJVN

Support can be found @ R8.05 - diagonal resistance @ R9.20. RDF and the J253 appear to be oversold at current levels.

PJVN

Mondi released a trading statement 1H 2019 - basic headline EPS ( euro cents) 93 to 99 (2018: 85.1), an increase of between 9% and 16% - slightly above estimates. Short-term resistance @ R315 with diagonal support @ R304.50. Appears to be trading close to oversold levels.

PJVN

Mondi released a trading statement 1H 2019 - basic headline EPS (euro cents) 93 to 99 (2018: 85.1), an increase of between 9% and 16% - slightly above estimates. Short-term resistance @ R315 with diagonal support @ R304.50. Appears to be trading close to oversold levels.

PJVN

A nice break above the 200-day ma today - support around $190 - next resistance around $196

PJVN

Tencent plans to announce their 2019 Q1 results tomorrow. The 200-day MA followed by the 23.6% Fib retracement could be key support levels.

PJVN

Break below diagonal trendline can test support at R13.85. The 200-day MA at R14.21 could provide some resistance.

PJVN

Gilead Sciences, Inc. is expected to report earnings after market close. According to Zacks Investment Research, based on 7 analysts' forecasts, the consensus EPS forecast for the quarter is $1.53. The reported EPS for the same quarter last year was $1.37. Gilead under performed the XBI - S&P Biotech ETF since Q3 2016. Horizontal support at $60.32 will be a key...

PJVN

USD/ZAR trading slightly below the 200-DMA @ 14.11. The 38.2% fib retracement level @ 14.09 could act as a short-term resistance level. Support can be found around the up-sloping trendline 13.60.

PJVN

Since the share reached an intra-day high of R41.83 on the 25th of September it has declined by more than 21%. Support can be found at R31.97. Target price would be around the 23.6% Fib retracement at R35.45. Fundamentally Super Group appears to be offering value.

PJVN

Redefine has been trading in a range of between R10.64 and R9.35 since Q3 2018. It briefly broke out of the range yesterday and reached an intra-day low of R9.25 which now could act as a short-term support level. The 50-day MA @ R9.96 will be a resistance level. The SARB repo rate announcement on Thursday afternoon + Moody’s credit rating decision Friday could...

PJVN

Barloworld moved slightly higher yesterday to close at R125. 200-day ma at R126.28 could be a key resistance level. The 50-day ma @ 122.96 could provide some support. Should the 50-day ma cross above the 200-day ma it could be viewed as a bullish signal.

PJVN

200-day MA @ R33.27 could provide some resistance....if we gain momentum from here next level would be around R34.

PJVN

Stonger GBP could help the share out today. Test of the 50-day moving average @ R60.07 could be on the cards. Support around the 200-day MA @ R57.39.